Basic design considerations for clinical trials in oncology.
作者信息
Piantadosi S, Saijo N, Tamura T
机构信息
Oncology Biostatistics, Johns Hopkins Oncology Center, Baltimore, Maryland 21205.
出版信息
Jpn J Cancer Res. 1992 Jun;83(6):547-58. doi: 10.1111/j.1349-7006.1992.tb00124.x.
Abstract
摘要
相似文献
1
Basic design considerations for clinical trials in oncology.肿瘤学临床试验的基本设计考量
Jpn J Cancer Res. 1992 Jun;83(6):547-58. doi: 10.1111/j.1349-7006.1992.tb00124.x.
2
Evaluating the medical literature, Part III: Results and discussion.评估医学文献，第三部分：结果与讨论。
Ann Emerg Med. 1983 Nov;12(11):679-86. doi: 10.1016/s0196-0644(83)80416-8.
3
An overview of the 1978 international meeting on comparative therapeutic trials.1978年比较治疗试验国际会议综述
Biomedicine. 1978 Sep;28 Spec No:6-13.
4
[Ethics of randomization].[随机化的伦理学]
Biomed Pharmacother. 1984;38(9-10):426-9.
5
Pathology is a necessary and informative tool in oncology clinical trials.病理学是肿瘤临床试验中必要且有价值的工具。
J Pathol. 2014 Jan;232(2):185-9. doi: 10.1002/path.4261.
6
CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.CT2——临床试验控制塔：克服肿瘤学临床试验启动的障碍
J Clin Oncol. 2007 Apr 1;25(10):1288; author reply 1288. doi: 10.1200/JCO.2006.10.3200.
7
[Randomized clinical trials].[随机临床试验]
Vopr Onkol. 1982;28(4):70-2.
8
Ethical issues in oncology biostatistics.肿瘤生物统计学中的伦理问题。
Stat Methods Med Res. 2002 Oct;11(5):429-48. doi: 10.1191/0962280202sm301ra.
9
[Basic concepts in pharmacology: important terms in pharmacodynamics and pharmacokinetics].[药理学基本概念：药效学和药代动力学中的重要术语]
Onkologie. 2008;31 Suppl 2:21-4. doi: 10.1159/000113446. Epub 2008 Apr 18.
10
Emotion and empiricism.情感与经验主义。
Br Med J. 1979 Feb 3;1(6159):288-9.
引用本文的文献
1
Highlights for ESMO 40: celebration review for lifetime achievement awards.欧洲肿瘤内科学会（ESMO）40周年亮点：终身成就奖庆典回顾
ESMO Open. 2016 Feb 17;1(1):e000010. doi: 10.1136/esmoopen-2015-000010. eCollection 2016.
2
Methodologies for evaluating HIV prevention intervention (populations and epidemiologic settings).评估艾滋病毒预防干预措施的方法（人群和流行病学环境）。
Curr Opin HIV AIDS. 2009 Jul;4(4):274-8. doi: 10.1097/COH.0b013e32832c2553.
3
Guidelines for analysis and reporting of clinical trials in oncology.肿瘤学临床试验分析与报告指南。
Jpn J Cancer Res. 1993 Sep;84(9):929-37. doi: 10.1111/j.1349-7006.1993.tb00180.x.
本文引用的文献
1
A simple approximation for calculating sample sizes for comparing independent proportions.一种用于计算比较独立比例时样本量的简单近似方法。
Biometrics. 1980 Jun;36(2):343-6.
2
The historical development of clinical therapeutic trials.
J Chronic Dis. 1959 Sep;10:218-48. doi: 10.1016/0021-9681(59)90004-9.
3
Why data bases should not replace randomized clinical trials.为何数据库不应取代随机临床试验。
Biometrics. 1980 Jun;36(2):337-42.
4
A treatment allocation procedure for sequential clinical trials.一种用于序贯临床试验的治疗分配程序。
Biometrics. 1980 Mar;36(1):81-90.
5
Methodology phase II clinical trial in cancer.癌症的II期临床试验方法学
Recent Results Cancer Res. 1980;70:53-60. doi: 10.1007/978-3-642-81392-4_5.
6
Randomized clinical trials: design and analysis.随机临床试验：设计与分析。
Semin Oncol. 1981 Dec;8(4):417-23.
7
Randomization by cluster. Sample size requirements and analysis.整群随机化。样本量要求与分析。
Am J Epidemiol. 1981 Dec;114(6):906-14. doi: 10.1093/oxfordjournals.aje.a113261.
8
Optimal allocation for the comparison of proportions.
Biometrics. 1982 Dec;38(4):1003-9.
9
The ethics of the randomized clinical trial.随机临床试验的伦理学
N Engl J Med. 1982 Sep 16;307(12):719-24. doi: 10.1056/NEJM198209163071204.
10
Timely topics in statistical methods for clinical trials.
Annu Rev Biophys Bioeng. 1982;11:81-104. doi: 10.1146/annurev.bb.11.060182.000501.
Zotero 插件